Table 2.
LDM | NLDM | P value | |
---|---|---|---|
No. of patients | 11 | 13 | – |
Previous embryo transfer | 1.28 ± 0.72 | 1.21 ± 0.72 | 0.3130a |
Multigravida patients | 4 (36.3%) | 3 (23.0%) | 0.4755b |
Multipara patients | 1 (9.0%) | 2 (15.4%) | 0.6423b |
Patients with miscarriage | 3 (27.2%) | 1 (7.7%) | 0.1997b |
Patients with chronic endometriosis | 2 (18.1%) | 3 (23.1%) | 0.8381b |
Patients with endometriosis | 0 | 0 | – |
Patients with endometrial polyp | 2 (18.1%) | 1 (7.7%) | 0.4374b |
Serum AMH, ng/mL | 3.33 ± 2.93 | 3.33 ± 2.68 | 0.7677a |
Serum TSH >2.50 μIU/mL | 3 (27.2%) | 3 (23.1%) | 0.7085b |
% of endometrial Lactobacillus* | 99.0 (93.5–99.9) | 20.7 (0.1–89.6) | – |
aStudent’st-test; bChi-square test; *Values are presented as median (range)
AMH, anti-mullerian hormone; CE, chronic endometritis; ET, embryo transfer; LDM, Lactobacillus-dominated microbiota; NLDM, non-Lactobacillus-dominated microbiota; TSH, thyroid stimulating hormone.